U.S. Pharma Stock News

Newmark Group (NMRK) has been in focus after a 4.2% share price move, alongside strong May retail sales data and a series of sizeable commercial real estate and digital infrastructure deals. See our latest analysis for Newmark Group. That 4.2% move sits within a mixed pattern, with the 7-day share price return of 7.23% partly offsetting a 30-day share price decline of 9.38%. The 1-year total shareholder return of 28.60% points to stronger longer term momentum. Recent headlines around the...

Matson’s recent earnings report showed a year-on-year revenue decline and a revenue miss versus analyst forecasts, but operating income surpassed expectations thanks to stronger post-Lunar New Year freight demand on its China service. Weaker volumes in Hawaii and Alaska reduced domestic logistics income, suggesting Matson’s earnings profile is increasingly influenced by the performance of its international China-linked operations. We’ll now examine how the stronger-than-expected operating...

Earlier this quarter, AMETEK reported record first-quarter 2026 results, with sales up 11% year over year and adjusted EPS rising 13%, and management raised full-year adjusted EPS guidance while projecting high-single-digit sales growth and double-digit Q2 EPS growth. Beyond the headline records, the stronger outlook signals management’s confidence that demand for AMETEK’s higher-value instrumentation and automation solutions remains resilient across key end markets. We’ll now examine how...

Recently, Materion received an analyst upgrade to a more favorable rating, reflecting increased confidence in its earnings outlook and underlying business performance. This shift in analyst sentiment highlights how rising earnings estimates can influence investor expectations for a company focused on advanced engineered materials. Next, we’ll examine how this more optimistic earnings outlook might reshape Materion’s existing investment narrative and risk-reward profile. Capitalize on the AI...

In early June 2026, Viavi Solutions introduced its first NITRO AI “AI Experts” suite and the ultra-compact µPNT GDO-1000 timing module, embedding task-specific AI guidance and advanced GNSS-disciplined timing directly into its test and measurement platforms for wireless, lab, and mission-critical applications. By fusing AI-driven automation with precision timing hardware across wireless, data center, and defense uses, Viavi is deepening its role inside increasingly complex, software-defined...

In early June 2026, Sabra Health Care REIT drew fresh attention after posting better-than-expected first-quarter results and presenting at Nareit REITweek in New York, where senior leaders outlined the company’s latest updates to investors. This stronger quarter, combined with public support from asset manager Jenny Van Leeuwen Harrington on CNBC, has refocused investors on Sabra’s fundamentals following a recent losing streak. Building on this combination of a robust quarterly report and...

Harrow recently re-launched VERKAZIA (cyclosporine ophthalmic emulsion) 0.1% in the US for vernal keratoconjunctivitis, backed by a commercial push around physician education, patient access, and affordability for this serious allergic eye disease that primarily affects children. The move reintroduces what has been described as a steroid-sparing therapy option into a market where many pediatric VKC patients remain inadequately controlled and long-term steroid use carries meaningful safety...

Recent performance snapshot Albemarle (ALB) has drawn fresh attention after a period of weak share performance, with the stock down about 3.6% on the day, 12.5% over the past week, and 30% over the past month. See our latest analysis for Albemarle. These short term share price losses sit alongside a year to date share price return of 2.3% and a very large 1 year total shareholder return, suggesting recent momentum has faded after a strong rebound. If Albemarle's swings have you thinking about...

CNO Financial Group recently hit a new 52-week high after reporting a series of earnings results that exceeded consensus estimates, including April’s US$1.29 per-share figure versus expectations of US$0.91. This consistent pattern of earnings outperformance, coupled with positive analyst estimate revisions and favorable value metrics, is drawing increased attention to CNO’s execution and earnings quality. Next, we’ll examine how this sustained earnings outperformance and analyst optimism may...

If you are wondering whether Goosehead Insurance at US$38.62 offers value or just extra risk, the key is to peel back the recent share price moves and see what they imply about the stock. The share price is up 12.4% over the past week, even though it is down 3.8% over the past month, 45.0% year to date, and 64.1% over the past year, which naturally raises questions about what the market is now pricing in. Recent coverage has focused on Goosehead Insurance's position in the US insurance...

Ross Stores (ROST) recently caught investors’ attention after reporting earnings and sales that topped expectations, alongside strong comparable store growth and higher full year guidance that reinforced management’s confidence in its expansion plans. See our latest analysis for Ross Stores. The strong earnings surprise and upbeat guidance have fed into solid momentum, with the share price delivering a 25.56% year to date share price return and a 65.29% total shareholder return over the past...

Without a specific news event driving the move, Liberty Latin America (LILA) has drawn attention after recent share price gains and a value score of 5, prompting fresh questions about how its fundamentals stack up today. See our latest analysis for Liberty Latin America. At a share price of US$7.86, Liberty Latin America’s recent gains sit alongside an 8.26% year to date share price return and a 51.15% total shareholder return over one year. This suggests improving momentum despite weaker...

Apple Hospitality REIT (APLE) has caught investor attention after earning a Momentum Style Score of A and a Zacks Rank of #2 (Buy), with shares outperforming both the broader REIT industry and the S&P 500. See our latest analysis for Apple Hospitality REIT. At a share price of $15.92, Apple Hospitality REIT has seen strong momentum, with a 30 day share price return of 12.67%, a 90 day share price return of 31.46% and a 1 year total shareholder return of 45.03%, with recent attention helped by...

Interface (TILE) has put new product design in the spotlight by unveiling its Forest Within carpet tiles, Cut & Form luxury vinyl tile, and noravant rubber flooring, all centered on biophilic, PVC free, sustainability focused flooring systems. See our latest analysis for Interface. These launches come against a backdrop of steady gains in the stock, with a 90 day share price return of 9.93% and a 1 year total shareholder return of 44.20%. The recent 1 day share price decline of 3.03% follows...

Rising inflation at 4.2% and the prospect of further Fed rate hikes are reshaping how banks and insurers are priced and perceived. Higher interest rates can alter funding costs, loan demand and investment income, creating both pressure and opportunity across financial stocks. This article focuses on three large companies from the US, UK and Canada that appear well placed within this backdrop, based on sector classification and financial metrics in our screener. Read on to see which three...

With US CPI inflation at 4.2% in May and the Federal Reserve signaling a longer period of steady or possibly higher rates, many investors are rethinking which stocks might handle rising prices more effectively. This article looks at a curated Inflation-Resilient Consumer Staples screener, built around large, established companies that may have some ability to cope with higher input and fuel costs. You will see 3 stocks from this list that are currently closely tied to the latest inflation...

In early June 2026, Science Applications International Corp. reported first-quarter fiscal 2027 results showing higher sales of US$1,906 million and a jump in net income to US$115 million, alongside a new US$50.6 million follow-on U.S. Navy task order to modernize advanced torpedo defense systems and continued share repurchases and dividends. Together with a lead role on the U.S. Air Force’s Advanced Battle Management System Digital Infrastructure Network Developer program, these awards...

If you are wondering whether Palantir Technologies stock is priced for perfection or still offers value, the recent share performance gives plenty to think about. At a last close of US$132.07, the stock is down 13.2% over the past week, down 4.2% over the past month and down 21.3% year to date, after a very large 3 year return of around 7x and a 5 year return of 441.0%, while the 1 year return is a decline of 0.6%. Recent headlines have focused on Palantir's role in data analytics for...

Riot Platforms (RIOT) is drawing fresh attention after partnering with Terrestrial Energy to explore molten salt nuclear reactors for future AI focused data centers, while also confronting a patent infringement lawsuit tied to cooling technology. See our latest analysis for Riot Platforms. Recent news around AI focused data centers, nuclear powered energy solutions and the cooling lawsuit comes as the stock trades at US$25.30, with a 90 day share price return of 70.8% and a 1 year total...

In early June 2026, National Beverage Corp. moved alongside a broad upswing in the non-alcoholic beverage sector, with investors rotating back into the group as a whole. The absence of major company-specific announcements or insider activity suggests the shift in sentiment was driven mainly by sector-wide buying rather than new information about National Beverage itself. With this sector-wide rally as a backdrop, we’ll explore how renewed investor interest in beverage stocks shapes National...

Apogee Therapeutics recently reported positive 16-week Phase 2 APEX data for its anti-IL-13 antibody zumilokibart in moderate-to-severe atopic dermatitis and entered a financing collaboration with Blackstone Life Sciences for up to US$1.30 billion in flexible, non-dilutive capital tied to future royalty payments. The combination of clinically meaningful efficacy, an extended dosing profile and a large, royalty-based funding package positions zumilokibart as a potential cornerstone asset in...

Earlier this month, Seadrill Limited filed a shelf registration for up to 1,400,000 common shares, totaling about US$63.94 million, to support an employee share ownership plan offering. This ESOP-related filing comes as Seadrill operates in an offshore drilling sector that is increasingly sensitive to fast-changing geopolitical tensions in the Middle East. With energy stocks pressured by US–Iran uncertainty, we'll explore how this geopolitical backdrop and Seadrill's ESOP filing shape its...

TKO Group Holdings recently declared a quarterly cash dividend of US$0.79 per Class A share, representing shareholders’ pro rata portion of an approximately US$150 million distribution from TKO Operating Company, paid on June 30, 2026 to investors of record as of June 15, 2026. This payout, combined with strong quarterly results and an expanded US$1 billion share repurchase authorization, highlights TKO’s emphasis on returning capital while balancing growth across UFC, WWE and lower-margin...

In early June 2026, Whirlpool Corporation priced an upsized US$2.00 billion offering of senior secured second-lien notes, carrying coupons of 7.500% due 2031 and 7.875% due 2034, to refinance near-term notes, repay its unsecured revolver, and fund related fees alongside a new asset-based revolving credit facility. This move replaces lower‑coupon debt with higher‑cost, asset‑backed borrowings, highlighting Whirlpool’s reliance on secured financing and the increased priority given to creditors...